Table: Brightpath Biotherapeutics - 9-MTH parent results

BrightPath Biotherapeutics Co

14/02/2020 06:00

Feb 14 (Reuters)- 
             Brightpath Biotherapeutics Co., Ltd. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended        Year to  
                Dec 31, 2019        Dec 31, 2018      Mar 31, 2020  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales             2 mln                                11 mln     
                                                       (-92.9 pct)  
  Operating       loss 1.32                             loss 2.42   
  Recurring       loss 1.32                             loss 2.42   
  Net             loss 1.34                             loss 2.44   
  EPS          loss 31.84 yen                        loss 57.89 yen 
  Ann Div                                NIL               NIL      
  -Q2 div            NIL                 NIL                        
  -Q4 div                                NIL               NIL      
  
  NOTE - Brightpath Biotherapeutics Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4594.T